These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2225364

  • 1. Effects of adenosine on human coronary arterial circulation.
    Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD.
    Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
    [Abstract] [Full Text] [Related]

  • 2. Effect of adenosine triphosphate on human coronary circulation.
    Shiode N, Kato M, Nakayama K, Shinohara K, Kurokawa J, Yamagata T, Matsuura H, Kajiyama G.
    Intern Med; 1998 Oct; 37(10):818-25. PubMed ID: 9840701
    [Abstract] [Full Text] [Related]

  • 3. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease.
    Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC.
    J Am Coll Cardiol; 1991 Sep; 18(3):718-29. PubMed ID: 1869735
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH, van Hagen E, Hendrix G, van Gelder B, Bech JW, Pijls NH.
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [Abstract] [Full Text] [Related]

  • 5. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG.
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [Abstract] [Full Text] [Related]

  • 6. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR.
    Circulation; 2003 Apr 15; 107(14):1877-83. PubMed ID: 12668522
    [Abstract] [Full Text] [Related]

  • 7. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M, Takenaka H, Uchikawa S, Nakatsuka T, Watanabe N, Sekiguchi M.
    Am J Cardiol; 1995 Feb 01; 75(4):246-50. PubMed ID: 7832132
    [Abstract] [Full Text] [Related]

  • 8. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine.
    Rossen JD, Quillen JE, Lopez AG, Stenberg RG, Talman CL, Winniford MD.
    J Am Coll Cardiol; 1991 Aug 01; 18(2):485-91. PubMed ID: 1856416
    [Abstract] [Full Text] [Related]

  • 9. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.
    Wilson RF, White CW.
    Circulation; 1986 Mar 01; 73(3):444-51. PubMed ID: 3948354
    [Abstract] [Full Text] [Related]

  • 10. Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist.
    Hodgson JM, Dib N, Kern MJ, Bach RG, Barrett RJ.
    Am J Cardiol; 2007 Jun 01; 99(11):1507-12. PubMed ID: 17531571
    [Abstract] [Full Text] [Related]

  • 11. [Inverse relationship between coronary flow velocity and myocardial oxygen extraction during intracoronary infusion of papaverine].
    Mikuniya A, Higashiyama A, Mikami M, Fujino Y, Sasaki N, Sasaki M, Fukushi T, Narita T, Onodera K, Oike Y.
    J Cardiol; 1992 Jun 01; 22(2-3):549-56. PubMed ID: 1339814
    [Abstract] [Full Text] [Related]

  • 12. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
    Christensen CW, Rosen LB, Gal RA, Haseeb M, Lassar TA, Port SC.
    Circulation; 1991 Jan 01; 83(1):294-303. PubMed ID: 1984887
    [Abstract] [Full Text] [Related]

  • 13. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve.
    Sonoda S, Takeuchi M, Nakashima Y, Kuroiwa A.
    Am Heart J; 1998 Apr 01; 135(4):621-7. PubMed ID: 9539477
    [Abstract] [Full Text] [Related]

  • 14. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.
    Zijlstra F, Juillière Y, Serruys PW, Roelandt JR.
    Cathet Cardiovasc Diagn; 1988 Apr 01; 15(2):76-80. PubMed ID: 3180211
    [Abstract] [Full Text] [Related]

  • 15. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA, Bouhasin A, Ciaramita JP, Khoukaz S, Herrmann SC, Kern MJ.
    Circulation; 2004 Mar 16; 109(10):1236-43. PubMed ID: 14993141
    [Abstract] [Full Text] [Related]

  • 16. Saline-Induced Coronary Hyperemia: Mechanisms and Effects on Left Ventricular Function.
    De Bruyne B, Adjedj J, Xaplanteris P, Ferrara A, Mo Y, Penicka M, Floré V, Pellicano M, Toth G, Barbato E, Duncker DJ, Pijls NH.
    Circ Cardiovasc Interv; 2017 Apr 16; 10(4):. PubMed ID: 28400462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement.
    Yoon MH, Tahk SJ, Yang HM, Park JS, Zheng M, Lim HS, Choi BJ, Choi SY, Choi UJ, Hwang JW, Kang SJ, Hwang GS, Shin JH.
    Am Heart J; 2009 Jun 16; 157(6):1050-6. PubMed ID: 19464416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.